These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 4413425

  • 21. [1st report on programmed chemotherapy of ovarian carcinoma].
    Frank S, Richter K, Ehrhart H, Penning W, Meister P, Schmidt D, Götz A.
    Fortschr Med; 1975 Oct 09; 93(28):1309-12. PubMed ID: 1228086
    [Abstract] [Full Text] [Related]

  • 22. Primary malignant tumors of the ovary: analysis of 124 cases.
    Tawil E, Methot Y.
    J Can Assoc Radiol; 1971 Jun 09; 22(2):130-5. PubMed ID: 4327461
    [No Abstract] [Full Text] [Related]

  • 23. Serum fibrinogen/fibrin degradation products in patients with ovarian carcinoma.
    Lalos O, Frankendal B, Rudolphi O.
    Ann Chir Gynaecol; 1977 Jun 09; 66(3):131-134. PubMed ID: 327909
    [Abstract] [Full Text] [Related]

  • 24. Chemotherapy of ovarian cancer.
    Hreshchyshyn MM, Graham JB.
    Int Surg; 1967 Apr 09; 47(4):398-401. PubMed ID: 4962186
    [No Abstract] [Full Text] [Related]

  • 25. [Postoperative Cobalt-60-teletherapy and intraperitoneal Gold-198 administration in malignant ovarian tumors].
    Reinhard B, Evers R.
    Strahlentherapie; 1974 Sep 09; 148(3):235-41. PubMed ID: 4446039
    [No Abstract] [Full Text] [Related]

  • 26. [Tissue reaction in ovarian carcinoma after cyclophosphamide (Endoxan) therapy].
    Engeler V, Hanski W.
    Pathol Microbiol (Basel); 1969 Sep 09; 33(3):153-60. PubMed ID: 5350583
    [No Abstract] [Full Text] [Related]

  • 27. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE.
    Obstet Gynecol; 1984 Oct 09; 64(4):564-72. PubMed ID: 6207473
    [Abstract] [Full Text] [Related]

  • 28. [Radiotherapy of malignant ovarian tumors using 42 megavolt photons].
    Halama J, Fiebach O.
    Fortschr Geb Rontgenstr Nuklearmed; 1972 Oct 09; ():Suppl:7-8. PubMed ID: 4344611
    [No Abstract] [Full Text] [Related]

  • 29. [New trends in treatment of ovarian carcinoma (author's transl)].
    Janisch H, Szalay S.
    Zentralbl Gynakol; 1982 Oct 09; 104(8):449-62. PubMed ID: 6810582
    [Abstract] [Full Text] [Related]

  • 30. [Immediate results of sarcolysine therapy of patients with malignant tumors of the ovaries].
    Semenovskiĭ AV.
    Vopr Onkol; 1983 Oct 09; 29(3):54-7. PubMed ID: 6836988
    [Abstract] [Full Text] [Related]

  • 31. Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer.
    Everett EN, French AE, Stone RL, Pastore LM, Jazaeri AA, Andersen WA, Taylor PT.
    Am J Obstet Gynecol; 2006 Aug 09; 195(2):568-74; discussion 574-6. PubMed ID: 16890558
    [Abstract] [Full Text] [Related]

  • 32. [Clinico-morphological characteristics and results of treatment of endometrioid cystadenocarcinoma of the ovary].
    Vinokurov VL, Livshits MA, Tsyrlina EV, Kolosov AE.
    Vopr Onkol; 1983 Aug 09; 29(12):49-56. PubMed ID: 6420990
    [Abstract] [Full Text] [Related]

  • 33. Whole abdominal and pelvic irradiation in patients with minimal disease at second-look surgical reassessment for ovarian carcinoma.
    Hoskins WJ, Lichter AS, Whittington R, Artman LE, Bibro MC, Park RC.
    Gynecol Oncol; 1985 Mar 09; 20(3):271-80. PubMed ID: 3972290
    [Abstract] [Full Text] [Related]

  • 34. Carcinoembryonic antigen (CEA) in ovarian cancer: factors influencing its incidence and changes which occur in response to cytotoxic drugs.
    Khoo SK, MacKay EV.
    Br J Obstet Gynaecol; 1976 Oct 09; 83(10):753-9. PubMed ID: 990213
    [Abstract] [Full Text] [Related]

  • 35. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S, Yeap B, Vogl S, Carbone P.
    Cancer; 1996 Feb 15; 77(4):733-42. PubMed ID: 8616766
    [Abstract] [Full Text] [Related]

  • 36. Mesonephroid tumors of the ovary. Clinical and histopathologic studies.
    Aure JC, Høeg K, Kolstad P.
    Obstet Gynecol; 1971 Jun 15; 37(6):860-7. PubMed ID: 4378209
    [No Abstract] [Full Text] [Related]

  • 37. [Efficacy of mono- and polychemotherapy in patients with advanced ovarian cancer].
    Khasanova DT, Kotova DG.
    Vopr Onkol; 1984 Jun 15; 30(3):67-71. PubMed ID: 6369776
    [Abstract] [Full Text] [Related]

  • 38. [Prognostic factors and better survival rate after the treatment of advanced ovarian cancer with neoadjuvant chemotherapy].
    Ivanov S, Ivanov S, Khadzhiolov N.
    Akush Ginekol (Sofiia); 2004 Jun 15; 43(6):17-9. PubMed ID: 15669647
    [Abstract] [Full Text] [Related]

  • 39. [Ovarian adenocarcinomas: 5 year results of treatment of 157 cases irradiated at Fondation Curie (1956-1968)].
    Mathieu G, Fenton J, Rousseau J.
    Bull Cancer; 1974 Jun 15; 61(2):161-76. PubMed ID: 4219286
    [No Abstract] [Full Text] [Related]

  • 40. The treatment of advanced cystadenocarcinoma of the ovary with gestronol and continuous oral cyclophosphamide.
    Guthrie D.
    Br J Obstet Gynaecol; 1979 Jul 15; 86(7):497-500. PubMed ID: 476014
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.